EXS3:F:F-iShares MDAX® UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 212.65

Change

-3.25 (-1.51)%

Market Cap

N/A

Volume

1.58K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.06 (+0.11%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.01 (+0.02%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.65 (+0.27%)

USD 53.24B
VUSA:F Vanguard Funds Public Limited ..

+0.97 (+1.01%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.39 (-0.40%)

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.14 (+0.09%)

USD 37.92B

ETFs Containing EXS3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.17% 14% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.17% 12% F 35% F
Trailing 12 Months  
Capital Gain -6.57% 16% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.57% 14% F 34% F
Trailing 5 Years  
Capital Gain -2.66% 29% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.66% 29% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 1.43% 43% F 49% F
Dividend Return 1.43% 41% F 43% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.88% 23% F 64% D
Risk Adjusted Return 7.17% 38% F 43% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.